Jump to Main Contents
国立がん研究センター 中央病院

Home > MoU signed between NCC and Siriraj Hospital, Mahidol University,
Thailand, June 2022.

MoU signed between NCC and Siriraj Hospital, Mahidol University,
Thailand, June 2022.

News & Events

MoU signed between NCC and Siriraj Hospital, Mahidol University, Thailand, June 2022.

In June 2022, a Memorandum of Understanding (MoU) was signed with Siriraj Hospital, Mahidol University, Thailand.

Siriraj Hospital is one of the most contributing institutions participating in ATLAS project, which is funded by Japan Agency for Medical Research and Development (AMED).

Especially, in 2022 April, the Director of Siriraj Institution of Clinical Research (SICRES), Prof. Kulkanya, gave a presentation at the ATLAS international symposium in Bangkok, they also generously hosted our representatives at their hospital, where a meeting between faculty of Siriraj Hospital and ATLAS leaders were held.

  • SICRES_20220425_1.jpg

    With SICRES Member

  • SIRIRAJ_HP_20220425_1.jpg

    We were guided in Siriraj HP

  • SIRIRAJ_HP_20220425_5.jpg

    Group photo with executives

  • SIRIRAJ_HP_20220425_4.jpg

    Discuss about our future

Following the signing of the MoU, NCC specialists made presentations at their webinar on early phase clinical trials. Dr. Yamamoto, the Deputy Director of NCC, Mr. Imaizumi, and Ms. Araki lectured on “FIH Clinical Trial: sharing experience from the National Cancer Center Hospital, Japan” sharing with the audience their academic experiences.

  • SICRES_Seminar_20220706_1.png

    The Seminar conducted by SICRES with NCC Clinical Research expert members.

  • SICRES_Seminar_20220706_1_2.png

    Three from NCC made presentations. 

The conclusion of the MoU is expected to further develop the cooperative relationship between the two institutions.